Back to search

KLINISK-Klinisk forskning

Intermittent beta cell rest by diazoxide: a new therapy in type 2 diabetes?

Awarded: NOK 0.43 mill.

Funding scheme:

KLINISK-Klinisk forskning

Thematic Areas and Topics

No thematic area or topic related to the project